Acute effects of acrolein in human volunteers during controlled exposure

Inhalation Toxicology

Volumn 27, Issue 14, 2015, Pages 810-821

  Dwivedi, Aishwarya M ^a   Johanson, Gunnar ^a   Lorentzen, Johnny C ^a   Palmberg, Lena ^a   Sjögren, Bengt ^a   Ernstgård, Lena ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Human exposure; indoor air; induced sputum; inflammation; irritation; smell; subjective ratings

Indexed keywords

ACETIC ACID ETHYL ESTER; ACROLEIN; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CARBON DIOXIDE; CLARA CELL PROTEIN; FIBRINOGEN; INTERLEUKIN 6; INTERLEUKIN 8; SERUM AMYLOID A; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER; FRAGRANCE;

ADULT; AIR; ARTICLE; BLOOD ANALYSIS; CELL COUNT; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOSE RESPONSE; ELECTROMYOGRAPHY; ENVIRONMENTAL EXPOSURE; EYE IRRITATION; EYELID REFLEX; FEMALE; FRIEDMAN TEST; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE DIFFERENTIAL COUNT; LUNG FUNCTION TEST; MALE; NORMAL HUMAN; NOSE CAVITY; NOSE IRRITATION; OCCUPATIONAL EXPOSURE; ODOR; PRIORITY JOURNAL; REST; SPUTUM ANALYSIS; SWELLING; VISUAL ANALOG SCALE; BLOOD CLOTTING; CHEMICALLY INDUCED; CHEMISTRY; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG EFFECTS; EYE DISEASE; INFLAMMATION; PILOT STUDY; SPUTUM;

ACROLEIN; BIOMARKERS; BLOOD COAGULATION; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE DISEASES; FEMALE; HUMANS; INFLAMMATION; MALE; ODORANTS; PILOT PROJECTS; SPUTUM;

EID: 84951568070     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2015.1115567     Document Type: Article

References (41)

1. Alarie Y. (1966). Irritating properties of airborne materials to the upper respiratory tract. Arch Environ Health 13: 433-49
2. Azuma K, Uchiyama I, Ikeda K. (2007). The risk screening for indoor air pollution chemicals in Japan. Risk Anal 27: 1623-38
3. Bautista DM, Jordt SE, Nikai T, et al. (2006). TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124: 1269-82
4. Beauchamp RO, Jr., Andjelkovich DA, Kligerman AD, et al. (1985). A critical review of the literature on acrolein toxicity. Crit Rev Toxicol 14: 309-80
5. Bottai M, Cai B, McKeown RE. (2010). Logistic quantile regression for bounded outcomes. Stat Med 29: 309-17
6. Brook RD, Rajagopalan S, Pope CA III, et al. (2010). Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 121: 2331-78
7. CICAD. (2002). CICAD. Concise International Chemical Assessment Document (Acrolein). Geneva: World Health Organization. 43 p
8. Conklin DJ, Prough RA, Juvan P, et al. (2011). Acrolein-induced dyslipidemia and acute-phase response are independent of HMG-CoA reductase. Mol Nutr Food Res 55: 1411-22
9. Cotes JE, Chinn DJ, Reed JW. (1997). Lung function testing: methods and reference values for forced expiratory volume (FEV1) and transfer factor (TL). Occup Environ Med 54: 457-65
10. Doty RL, Cometto-Muniz JE, Jalowayski AA, et al. (2004). Assessment of upper respiratory tract and ocular irritative effects of volatile chemicals in humans. Crit Rev Toxicol 34: 85-142
11. Ernstgård L, Iregren A, Juran S, et al. (2009a). Acute effects of exposure to vapours of standard and dearomatized white spirits in humans. 2. Irritation and inflammation. J Appl Toxicol 29: 263-74
12. Ernstgård L, Iregren A, Sjögren B, et al. (2006a). Acute effects of exposure to vapours of acetic acid in humans. Toxicol Lett 165: 22-30
13. Ernstgård L, Iregren A, Sjögren B, et al. (2006b). Acute effects of exposure to vapours of dioxane in humans. Hum Exp Toxicol 25: 723-9
14. Ernstgård L, Iregren A, Sjögren B, et al. (2006c). Acute effects of exposure to hexanal vapors in humans. J Occup Environ Med 48: 573-80
15. Ernstgård L, Lind B, Johanson G. (2009b). Acute effects of exposure to vapours of standard and dearomatized white spirits in humans. 1. Dose-finding study. J Appl Toxicol 2: 255-62
16. Ernstgård L, Sjögren B, Johanson G. (2012). Acute effects of exposure to vapors of hydrogen peroxide in humans. Toxicol Lett 212: 222-7
17. Esterbauer H, Schaur RJ, Zollner H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128
18. Faroon O, Roney N, Taylor J, et al. (2008a). Acrolein environmental levels and potential for human exposure. Toxicol Ind Health 24: 543-64
19. Faroon O, Roney N, Taylor J, et al. (2008b). Acrolein health effects. Toxicol Ind Health 24: 447-90
20. Ghilarducci DP, Tjeerdema RS. (1995). Fate and effects of acrolein. Rev Environ Contam Toxicol 144: 95-146
21. Grafström RC, Sundqvist K, Dypbukt JM, Harris CC. (1987). Pathobiological effects of aldehydes in cultured human bronchial cells. IARC Sci Publ 84: 443-5
22. IARC. (1995). Acrolein. IARC Monogr Eval Carcinog Risks Hum 63: 337-72
23. Kehrer JP, Biswal SS. (2000). The molecular effects of acrolein. Toxicol Sci 57: 6-15
24. Kim H, Mittal DP, Iadarola MJ, et al. (2006). Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J Med Genet 43: e40
25. Lang I, Bruckner T, Triebig G. (2008). Formaldehyde and chemosensory irritation in humans: a controlled human exposure study. Regul Toxicol Pharmacol 50: 23-36
26. Logue JM, Small MJ, Stern D, et al. (2010). Spatial variation in ambient air toxics concentrations and health risks between industrial-influenced, urban, and rural sites. J Air Waste Manag Assoc 60: 271-86
27. Miller MR, Hankinson J, Brusasco V, et al. (2005). Standardisation of spirometry. Eur Respir J 26: 319-38
28. Nagata Y. (2003). Measurement of odor threshold by triangle odor bag method. International Symposium on Odor Measurement. Asian Network on Odor Measurement and Control. Japan Association on Odor Environment; Tokyo, Japan; 118-127
29. Nihlén A, Löf A, Johanson G. (1998). Controlled ethyl tert-butyl ether (ETBE) exposure of male volunteers II. Acute effects in humans. Toxicol Appl Pharmacol 148: 281-7
30. Paoletti P, Pistelli G, Fazzi P, et al. (1986). Reference values for vital capacity and flow-volume curves from a general population study. Bull Eur Physiopathol Respir 22: 451-9
31. Seaman VY, Bennett DH, Cahill TM. (2007). Origin, occurrence, and source emission rate of acrolein in residential indoor air. Environ Sci Technol 41: 6940-6
32. Shusterman D, Matovinovic E, Salmon A. (2006). Does Habers law apply to human sensory irritation? Inhal Toxicol 18: 457-71
33. Sierra LM, Barros AR, Garcia M, et al. (1991). Acrolein genotoxicity in Drosophila melanogaster. I. Somatic and germinal mutagenesis under proficient repair conditions. Mutat Res 260: 247-56
34. Sim VM, Pattle RE. (1957). Effect of possible smog irritants on human subjects. J Am Med Assoc 165: 1908-13
35. Strandberg K, Ek A, Palmberg L, et al. (2008). Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness. J Intern Med: 83-94
36. Swedish Work Environment Authority. (2011). Occupational exposure limits. AFS 2011:18
37. Taylor G, Macneil AR, Freed DL. (1973). Assessing degree of nasal patency by measuring peak expiratory flow rate through the nose. J Allergy Clin Immunol 52: 193-8
38. Van Eeden SF, Tan WC, Suwa T, et al. (2001). Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med 164: 826-30
39. Weber-Tschopp A, Fischer T, Gierer R, et al. (1977). [Experimentally induced irritating effects of acrolein on men (authors transl)]. Int Arch Occup Environ Health 40: 117-30
40. Weber A, Jermini C, Grandjean E. (1976). Irritating effects on man of air pollution due to cigarette smoke. Am J Public Health 66: 672-6
41. Wålinder R, Norbäck D, Wieslander G, et al. (1998). Nasal patency and biomarkers in nasal lavage-The significance of air exchange rate and type of ventilation in schools. Int Arch Occup Environ Health 71: 479-86